These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12638270)
21. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Mitsuyama K; Sata M Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340 [TBL] [Abstract][Full Text] [Related]
22. Probiotics and intestinal inflammatory disorders in infants and children. Vanderhoof JA J Pediatr Gastroenterol Nutr; 2000; 30 Suppl 2():S34-8. PubMed ID: 10749399 [No Abstract] [Full Text] [Related]
23. Gastroenteric pathology and probiotics: from myth to scientific evidence. Current aspects. Caramia G Minerva Gastroenterol Dietol; 2009 Sep; 55(3):237-72. PubMed ID: 19829283 [TBL] [Abstract][Full Text] [Related]
24. Solute carriers (SLC) in inflammatory bowel disease: a potential target of probiotics? Kotka M; Lieden A; Pettersson S; Trinchieri V; Masci A; D'Amato M J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S133-5. PubMed ID: 18806705 [TBL] [Abstract][Full Text] [Related]
25. Review article: probiotics and prebiotics in irritable bowel syndrome. Spiller R Aliment Pharmacol Ther; 2008 Aug; 28(4):385-96. PubMed ID: 18532993 [TBL] [Abstract][Full Text] [Related]
26. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. Camilleri M J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702 [TBL] [Abstract][Full Text] [Related]
27. [New therapies of chronic inflammatory bowel disease: anti-TNF antibodies and probiotics. The Danish Society of Gastroenterology]. Kjeldsen J; Brynskov J; Madsen JR Ugeskr Laeger; 2001 Mar; 163(12):1707. PubMed ID: 11284407 [No Abstract] [Full Text] [Related]
28. [Efficacy of probiotics in inflammatory bowel disease]. Mitsuyama K Nihon Rinsho; 2012 Feb; 70 Suppl 1():358-64. PubMed ID: 23126118 [No Abstract] [Full Text] [Related]
29. Evolving knowledge and therapy of inflammatory bowel disease. Korzenik JR; Podolsky DK Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373 [TBL] [Abstract][Full Text] [Related]
31. Do probiotics have a role in the management of inflammatory bowel disease? Morris JD; Diamond KA; Balart LA J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038 [TBL] [Abstract][Full Text] [Related]
32. Probiotics in inflammatory bowel disease: possible mechanisms of action. Dotan I; Rachmilewitz D Curr Opin Gastroenterol; 2005 Jul; 21(4):426-30. PubMed ID: 15930982 [TBL] [Abstract][Full Text] [Related]
33. Probiotics for chronic intestinal disorders. Guslandi M Am J Gastroenterol; 2003 Mar; 98(3):520-1. PubMed ID: 12650780 [No Abstract] [Full Text] [Related]
34. [Probiotic therapy: mechanisms of action and indications in adult gastrointestinal disease]. Glintborg B; Nielsen AM Ugeskr Laeger; 2004 Jan; 166(3):135-9. PubMed ID: 14870638 [No Abstract] [Full Text] [Related]
35. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Campieri M; Gionchetti P Gastroenterology; 1999 May; 116(5):1246-9. PubMed ID: 10220518 [No Abstract] [Full Text] [Related]
36. Effect of probiotics on intestinal barrier function. Mennigen R; Bruewer M Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305 [TBL] [Abstract][Full Text] [Related]